Role of RTN1A in the Progression of Diabetic Nephropathy
Role of RTN1A in the Progression of Diabetic Nephropathy
批准号:
10618132
负责人:
John Cijiang He
金额:
$45.15万
依托单位国家:
美国
项目类别:
财政年份:
2016
资助国家:
美国
项目状态:
已结题
起止时间:
2016-04-18 至 2024-03-31
关键词:
ATP Synthesis PathwayAcute Renal Failure with Renal Papillary NecrosisAlbuminsAlbuminuriaApoptosisApoptosis Regulation GeneApoptoticAttenuatedAutomobile DrivingAutophagocytosisCell LineCellsChronic Kidney FailureDNA copy numberDataData SetDevelopmentDiabetic NephropathyDiabetic mouseDisease ProgressionEnd stage renal failureEndoplasmic ReticulumEpithelial CellsEventFundingGenesGlucoseHK2 geneHumanImmunoprecipitationIn VitroIncidenceInflammasomeInflammationInjury to KidneyInterventionKidneyKidney DiseasesMass Spectrum AnalysisMeasuresMediatingMembraneMembrane PotentialsMitochondriaMitochondrial DNAMitochondrial ProteinsMusOxidative StressPathogenicityPathway interactionsPatientsPlayPrevalencePreventiveProductionProteinsRANK proteinRegimenRegulationRenal functionReportingRisk FactorsRoleSignal TransductionSiteStreptozocinTestingTherapeuticTherapeutic EffectTubular formationTunicamycinattenuationcell injurydb/db mousediabeticdiabetic patientendoplasmic reticulum stressglucose uptakehexokinasein vivoinhibitorkidney cellkidney fibrosisknock-downmitochondrial dysfunctionmouse modelnoveloverexpressionpleiotropismscreeningtranscriptomics
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Project Summary
Diabetic kidney disease (DKD) remains as the leading cause of ESRD in USA and the treatment options are
limited. Therefore, it is critical for us to identify contributing factors for the progression of DKD. By analyzing the
transcriptomic datasets in mouse models with different rates of disease progression, we identified Reticulon-1
(Rtn1), a gene encoding an endoplasmic reticulum (ER)-associated protein, as a risk factor for progression of
CKD. We found that RTN1A expression is markedly increased in the diseased kidney and inversely correlated
with eGFR in human with DKD. In vitro, we showed that RTN1A mediates ER stress and apoptosis in renal
tubular epithelial cells (RTEC). In vivo, we showed that a global knockdown of Rtn1a expression attenuated
albuminuria and kidney injury in streptozotocin (STZ)-induced diabetic mice. During the last funding period, we
further demonstrated that the induction of RTN1A expression in RTEC in the STZ-induced diabetic mice
resulted in the decline of renal function and development of renal fibrosis, which are not typically observed in
STZ-induced diabetic mice. Screening of RTN1A-interacting proteins surprisingly showed that the highly
ranked proteins were mitochondrial proteins, such as hexokinase 1 (HK1), TOMM40, and SLC25A12.
Consistent with this, a recent study also demonstrates a large amount of RTN1A in the ER-mitochondrial
contact sites. ER-mitochondrial contact (EMC), or also referred as mitochondria-associated ER membranes
(MAMs), have pleiotropic effects on a variety of intracellular events including mitochondrial damage, Ca2+
signaling, ER stress, apoptosis, and autophagy. However, the direct association of EMC with kidney disease
has not been reported. Our preliminary data showed that overexpression of RTN1A in HK2 cells induced not
only ER stress but also mitochondrial dysfunction. High glucose increased both ER stress and mitochondrial
dysfunction in HK2 cells, which was further aggravated by RTN1A overexpression. In vivo, diabetic mice with
RTN1A overexpression in RTEC had increased markers for both ER stress and mitochondrial dysfunction.
These data suggest a critical role of RTN1A in mediating both ER stress and mitochondrial dysfunction likely
through EMC. Also, we confirmed that RTN1A interacted with HK1 and induced the degradation of HK1 in
RTEC and HK1 is a key regulator of apoptosis and inflammasome activation. Based on these data, we
hypothesize that RTN1A-mediated EMC plays a critical role in inducing tubular cell injury and the progression
of DKD. To test this, we propose to determine 1) the role of RTN1A in mediating EMC in RTEC injury in
diabetic condition; 2) the mechanism of RTN1A-mediated EMC in RTEC injury in diabetic condition; and 3) the
potential interventions to regulate EMC as a therapy for DKD.
期刊论文(2)
专著(0)
科研奖励(0)
会议论文
Prostaglandin I2 Receptor Agonism for Proteinuria and Diabetes: Good for the Goose and Good for the Gander?
前列腺素 I2 受体激动剂治疗蛋白尿和糖尿病:对鹅和公鹅都有好处吗?
DOI:
10.2337/dbi16-0009
发表时间:
2016
期刊:
Diabetes
影响因子:
7.7
作者:
[Menon,MadhavC, He,JohnC]
通讯作者:
He,JohnC
Injury in nonaged podocytes as an accelerator of glomerular aging.
非衰老足细胞损伤是肾小球衰老的加速器。
DOI:
10.1152/ajprenal.00344.2023
发表时间:
2024
期刊:
American journal of physiology. Renal physiology
影响因子:
--
作者:
[Fang,Zhengying, Lee,Kyung, He,JohnCijiang]
通讯作者:
He,JohnCijiang
The role of Vpr-mediated cell cycle dysregulation in HIV-associated kidney disease
-
批准号:10678878
-
项目类别:
-
资助金额:$74.03万
-
财政年份:2022
-
负责人:John Cijiang He
-
依托单位:
The role of Vpr-mediated cell cycle dysregulation in HIV-associated kidney disease
-
批准号:10527702
-
项目类别:
-
资助金额:$77.92万
-
财政年份:2022
-
负责人:John Cijiang He
-
依托单位:
Role of RARRES1 in diabetic kidney disease
-
批准号:10278234
-
项目类别:
-
资助金额:$44.76万
-
财政年份:2021
-
负责人:John Cijiang He
-
依托单位:
Elucidating the Molecular Mechanisms that Mediate DKD Progression in Patients Living with HIV
-
批准号:10364063
-
项目类别:
-
资助金额:$85.86万
-
财政年份:2021
-
负责人:John Cijiang He
-
依托单位:
Role of RARRES1 in diabetic kidney disease
-
批准号:10662465
-
项目类别:
-
资助金额:$44.7万
-
财政年份:2021
-
负责人:John Cijiang He
-
依托单位:
Role of RARRES1 in diabetic kidney disease
-
批准号:10461883
-
项目类别:
-
资助金额:$44.7万
-
财政年份:2021
-
负责人:John Cijiang He
-
依托单位:
Elucidating the Molecular Mechanisms that Mediate DKD Progression in Patients Living with HIV
-
批准号:10531888
-
项目类别:
-
资助金额:$84.11万
-
财政年份:2021
-
负责人:John Cijiang He
-
依托单位:
PP2A as a drug target for diabetic kidney disease
-
批准号:10399582
-
项目类别:
-
资助金额:$58.95万
-
财政年份:2020
-
负责人:John Cijiang He
-
依托单位:
PP2A as a drug target for diabetic kidney disease
-
批准号:10627834
-
项目类别:
-
资助金额:$58.95万
-
财政年份:2020
-
负责人:John Cijiang He
-
依托单位:
Mechanisms mediating podocyte-parietal epithelial cell crosstalk in proliferative glomerulopathies
-
批准号:10434116
-
项目类别:
-
资助金额:$50.89万
-
财政年份:2020
-
负责人:John Cijiang He
-
依托单位:
Mechanisms mediating podocyte-parietal epithelial cell crosstalk in proliferative glomerulopathies
-
批准号:10119964
-
项目类别:
-
资助金额:$56.19万
-
财政年份:2020
-
负责人:John Cijiang He
-
依托单位:
Mechanisms mediating podocyte-parietal epithelial cell crosstalk in proliferative glomerulopathies
-
批准号:10264089
-
项目类别:
-
资助金额:$51.31万
-
财政年份:2020
-
负责人:John Cijiang He
-
依托单位:
PP2A as a drug target for diabetic kidney disease
-
批准号:10220959
-
项目类别:
-
资助金额:$58.95万
-
财政年份:2020
-
负责人:John Cijiang He
-
依托单位:
Mechanisms mediating podocyte-parietal epithelial cell crosstalk in proliferative glomerulopathies
-
批准号:10773886
-
项目类别:
-
资助金额:$7.35万
-
财政年份:2020
-
负责人:John Cijiang He
-
依托单位:
Mechanisms mediating podocyte-parietal epithelial cell crosstalk in proliferative glomerulopathies
-
批准号:10625384
-
项目类别:
-
资助金额:$50.89万
-
财政年份:2020
-
负责人:John Cijiang He
-
依托单位:
Role of RTN1A in the Progression of Diabetic Nephropathy
-
批准号:10380165
-
项目类别:
-
资助金额:$45.15万
-
财政年份:2016
-
负责人:John Cijiang He
-
依托单位:
Role of RTN1A in the Progression of Diabetic Nephropathy
-
批准号:9126016
-
项目类别:
-
资助金额:$38.14万
-
财政年份:2016
-
负责人:John Cijiang He
-
依托单位:
Role of HIPK2 in Kidney Tubulointerstitial Injury
-
批准号:8012025
-
项目类别:
-
资助金额:$41.33万
-
财政年份:2010
-
负责人:John Cijiang He
-
依托单位:
Role of HIPK2 in Kidney Tubulointerstitial Injury
-
批准号:8089385
-
项目类别:
-
资助金额:$34.53万
-
财政年份:2010
-
负责人:John Cijiang He
-
依托单位:
Role of HIPK2 in Kidney Tubulointerstitial Injury
-
批准号:8320387
-
项目类别:
-
资助金额:$34.53万
-
财政年份:2010
-
负责人:John Cijiang He
-
依托单位: